Geovax Labs Inc (GOVX)
2.95
+0.25
(+9.26%)
USD |
NASDAQ |
Nov 22, 16:00
2.91
-0.04
(-1.36%)
After-Hours: 20:00
Geovax Labs Cash from Financing (Quarterly): 16.35M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 16.35M |
| June 30, 2024 | 2.734M |
| March 31, 2024 | |
| December 31, 2023 | 4.062M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 7.626M |
| June 30, 2022 | 18.50M |
| March 31, 2022 | 9.229M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.23M |
| June 30, 2021 | -0.0258M |
| March 31, 2021 | 12.58M |
| December 31, 2020 | -0.0005M |
| September 30, 2020 | 11.16M |
| June 30, 2020 | 1.056M |
| March 31, 2020 | 0.2971M |
| December 31, 2019 | -0.0019M |
| September 30, 2019 | 0.6969M |
| June 30, 2019 | 0.4969M |
| March 31, 2019 | 0.2379M |
| December 31, 2018 | 0.25M |
| September 30, 2018 | 0.60M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.64M |
| December 31, 2017 | 0.4173M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 1.085M |
| March 31, 2017 | 0.0492M |
| December 31, 2016 | 0.3114M |
| September 30, 2016 | 0.6992M |
| June 30, 2016 | 0.091M |
| March 31, 2016 | 0.2382M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 2.680M |
| December 31, 2014 | 0.8734M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 1.616M |
| September 30, 2013 | -0.00 |
| June 30, 2013 | 0.5833M |
| March 31, 2013 | 1.06M |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.0258M
Minimum
Jun 2021
18.50M
Maximum
Jun 2022
4.655M
Average
0.6764M
Median
Cash from Financing (Quarterly) Benchmarks
| Abbott Laboratories | -1.576B |
| Emergent BioSolutions Inc | -180.30M |
| Tonix Pharmaceuticals Holding Corp | 42.90M |
| SIGA Technologies Inc | -0.2741M |
| Chimerix Inc | 0.178M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.297M |
| Cash from Investing (Quarterly) | -0.0207M |
| Free Cash Flow | -27.24M |
| Free Cash Flow Per Share (Quarterly) | -1.455 |
| Free Cash Flow to Equity (Quarterly) | -9.176M |
| Free Cash Flow Yield | -277.9% |